Annual Cash & Cash Equivalents
$35.72 M
-$6.93 M-16.24%
December 31, 2024
Summary
- As of March 12, 2025, NUVB annual cash & cash equivalents is $35.72 million, with the most recent change of -$6.93 million (-16.24%) on December 31, 2024.
- During the last 3 years, NUVB annual cash & cash equivalents has fallen by -$96.70 million (-73.02%).
- NUVB annual cash & cash equivalents is now -73.02% below its all-time high of $132.42 million, reached on December 31, 2021.
Performance
NUVB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$35.72 M
+$5.69 M+18.93%
December 31, 2024
Summary
- As of March 12, 2025, NUVB quarterly cash and cash equivalents is $35.72 million, with the most recent change of +$5.69 million (+18.93%) on December 31, 2024.
- Over the past year, NUVB quarterly cash and cash equivalents has increased by +$5.69 million (+18.93%).
- NUVB quarterly cash and cash equivalents is now -94.41% below its all-time high of $638.90 million, reached on March 31, 2021.
Performance
NUVB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NUVB Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.2% | +18.9% |
| 3 y3 years | -73.0% | +18.9% |
| 5 y5 years | +20.1% | +18.9% |
NUVB Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -73.0% | at low | -74.2% | +46.4% |
| 5 y | 5-year | -73.0% | +20.1% | -94.4% | +46.4% |
| alltime | all time | -73.0% | +20.1% | -94.4% | +46.4% |
Nuvation Bio Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $35.72 M(-16.2%) | $35.72 M(+18.9%) |
| Sep 2024 | - | $30.04 M(-12.4%) |
| Jun 2024 | - | $34.28 M(-0.7%) |
| Mar 2024 | - | $34.51 M(-19.1%) |
| Dec 2023 | $42.65 M(-57.8%) | $42.65 M(+74.8%) |
| Sep 2023 | - | $24.39 M(-51.3%) |
| Jun 2023 | - | $50.06 M(+66.5%) |
| Mar 2023 | - | $30.07 M(-70.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $101.10 M(-23.7%) | $101.10 M(-27.1%) |
| Sep 2022 | - | $138.69 M(+35.5%) |
| Jun 2022 | - | $102.32 M(-3.7%) |
| Mar 2022 | - | $106.21 M(-19.8%) |
| Dec 2021 | $132.42 M(+345.0%) | $132.42 M(-61.6%) |
| Sep 2021 | - | $344.63 M(-23.3%) |
| Jun 2021 | - | $449.53 M(-29.6%) |
| Mar 2021 | - | $638.90 M(+2047.2%) |
| Dec 2020 | $29.75 M | $29.75 M |
FAQ
- What is Nuvation Bio annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Nuvation Bio?
- What is Nuvation Bio annual cash & cash equivalents year-on-year change?
- What is Nuvation Bio quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Nuvation Bio?
- What is Nuvation Bio quarterly cash and cash equivalents year-on-year change?
What is Nuvation Bio annual cash & cash equivalents?
The current annual cash & cash equivalents of NUVB is $35.72 M
What is the all time high annual cash & cash equivalents for Nuvation Bio?
Nuvation Bio all-time high annual cash & cash equivalents is $132.42 M
What is Nuvation Bio annual cash & cash equivalents year-on-year change?
Over the past year, NUVB annual cash & cash equivalents has changed by -$6.93 M (-16.24%)
What is Nuvation Bio quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NUVB is $35.72 M
What is the all time high quarterly cash and cash equivalents for Nuvation Bio?
Nuvation Bio all-time high quarterly cash and cash equivalents is $638.90 M
What is Nuvation Bio quarterly cash and cash equivalents year-on-year change?
Over the past year, NUVB quarterly cash and cash equivalents has changed by +$5.69 M (+18.93%)